Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,819 across all filing types
Latest filing 2022-09-20 Foreign Filer Report
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
6-K
Foreign Filer Report
2022-09-20 English
6-K
Foreign Filer Report
2022-09-01 English
Regulatory Filings 2022
Regulatory Filings Classification · 1% confidence The provided document text consists almost entirely of a table showing transaction data, identified by columns like 'Volume', 'Price', 'Venue', and 'Time CET'. The content includes various numerical codes (1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16, 17, 18, 20, 22, 23, 24, 25, 26, 27, 30, 35, 37, 38, 39, 40, 41, 50) followed by price/volume data. These codes correspond to specific types of regulatory or market event announcements listed in the definitions (e.g., 10=Earnings Release, 13=Volume/Price data often associated with trading/share movement, 22=NAV, 23=Dividend Notice, etc.). Since the document is a raw dump of market activity data, likely related to trading or transaction reporting, and does not appear to be a narrative report, presentation, or formal regulatory filing document itself, the most appropriate classification is the general category for structured data or miscellaneous filings that don't fit elsewhere. Given the presence of codes that map to specific events (like 10 for ER, 22 for NAV, 23 for DIV), but presented in a raw, tabular format rather than a narrative release, the best fit among the provided options is either XLSX (if this was the data extracted from a spreadsheet) or RNS (as a general regulatory/market data feed). Since the format is a raw text table, and it contains codes for various events (including financial results (10), NAV (22), Dividend (23), Capital/Financing (6)), it strongly suggests a data feed or a collection of market updates. 'RNS' (Regulatory Filings/General regulatory announcements) is the best fallback for unstructured/raw data feeds that don't fit a specific narrative report type. However, the presence of '12' (Financial Supplement Data) and the highly structured, numerical nature of the data strongly suggests this is raw data, which often gets categorized as 'XLSX' if it represents the underlying data set, or 'RNS' if it's a regulatory dissemination of this data. Given the context of financial reporting databases, raw data feeds are often captured under RNS or sometimes XLSX if the structure implies spreadsheet content. Since it's not a narrative report, and it's a collection of market events, RNS is the safest general classification for a raw data dump that isn't a formal report.
2022-09-01 English
Completion of share buy-back program
Transaction in Own Shares Classification · 1% confidence The document is a formal company announcement from Genmab regarding the completion of a share buy-back program. It details the number of shares repurchased, the average price, and the total value, and confirms that the program has concluded. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2022-09-01 English
Completion of share buy-back program
Transaction in Own Shares Classification · 1% confidence The document is a company announcement from Genmab A/S regarding the completion of a share buy-back program. It details the number of shares repurchased, the average price, and the total value of the transactions, explicitly stating that the program has been completed. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2022-09-01 Danish
6-K
Foreign Filer Report
2022-08-29 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.